Rejected at 7:49 p.m. Feb, 23, 2024 ] by herstein.jacob
Author: Luckylucknut
Related Note: 1495892801267 3
Rationale for change

GINA update July 2023
https://ginasthma.org/wp-content/uploads/2023/07/GINA-2023-Full-report-23_07_06-WMS.pdf

For adults and adolescents, the preferred Step 3 treatment is the Track 1 regimen with low-dose ICS-formoterol as maintenance and reliever therapy (MART). This reduces the risk of severe exacerbations, with simiar or better symptom control, compared with maintenance treatment using a combination of an ICS and a long-acting beta2 agonist (LABA) as controller, plus as-needed SABA.

Other stap 3 options for adults and adolescents in Track 2, and in children, include maintenance ICS-LABA plus as-needed SABA or plus as-needed ICS-SABA (if available)

Rejection reason

Consensus that we are not moving to GINA right now

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Empty field
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME
Empty field
Additional Resources
One by one
Empty field
#AK_Step2_v12::#UWorld::COMLEX::101400 #AK_Step2_v12::#Resources_by_rotation::IM::uw::pulm_critical_care::pulm_critical_care_zanki #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::01_Pulmonary_Disease::02_Asthma #AK_Other::Only_Step_2 #AK_Step2_v12::Original_decks::Dorian::im::uw::pulm_cc #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::#UWorld::Step::4617 #AK_Other::AnKing_Image::Mujeeb::Asthma #AK_Step2_v12::#SketchyPeds::05_Respiratory_&_Pulmonology::02_Lower_Airway_Disease::03_Asthma_in_Children #PANCE::EOR::PEDS #AK_Step2_v12::#SketchyIM::03_Pulmonology::02_Obstructive_Pulmonary_Diseases::02_Chronic_Asthma_Management #AK_Step2_v12::#OME::Clinical::01_Medicine::02_Pulmonology::01_Asthma #AK_Step2_v12::!Shelf::IM::no_dupes::only_step2 #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::Pulm_&_Critical_Care #AK_Step2_v12::!Shelf::#Cards_AnKing_Did::6im #AK_Step2_v12::!Shelf::EM #AK_Other::AnKing_Image::!Subjects::Pulmonology::Asthma_management #AK_Step2_v12::#OME::01_Medicine::02_Pulmonology::01_Asthma #AK_Step2_v12::#Bootcamp::Medicine::02_Pulmonary_and_Critical_Care::01_Obstructive_Lung_Diseases::04_Chronic_Asthma_Management #AK_Step2_v12::#Resources_by_rotation::IM::uw::pulm_critical_care::pulm_critical_care_dorian #PANCE::EOR::Family_med #PANCE::PULM::obstructive_pulmonary_diseases #AK_Step2_v12::#Subjects::Pulmonology::05_Lungs::Obstructive_Lung_Disease::Asthma::Management_Redo #AK_Other::Table::Asthma_Treatment #AK_Step2_v12::#FirstAid::14_Pulm::01_Obstructive_Lung_Disease::02_Asthma #AK_Step2_v12::#Subjects::Pulmonology::05_Lungs::Obstructive_Lung_Disease::Asthma